| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |